Aclaris Therapeutics (ACRS) Stock Price, Quote, News & History | Benzinga

SPY777.35+0.02%QQQ758.48+0.10%BTC/USD83,167.36−2.78%DIA510.98−0.01%GLD377.04+0.31%TLT77.07−0.10%

Aclaris Therapeutics Inc (ACRS) Stock Price, Quote, News & History

ACRSNASDAQ

Trade with Public

Trade with Public

$3.40

-0.30-8.11%

Last update: Oct 7, 4:00 PM

$3.40

-0.30-8.11%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.60

Close

$3.40

Volume / Avg.

9.00M / 2.33M

Day Range

$3.32 - $3.62

52 Wk Range

1.74 - 6.60

Market Cap

$500.48M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

22

Short Interest

12.4%

Days to Cover

6.38

Recent Aclaris Therapeutics, Inc. News

Vipshop, Gorilla Technology Group And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

U.S. stock futures rise, Nasdaq 100 gains 200 points. Vipshop shares fall 4.9% after reporting Q2 earnings below expectations. Other stocks dip in pre-market trading.

Avi Kapoor

Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Shares of Cadeler A/S (NYSE: CDLR) surged in pre-market trading after reporting strong financial results for the first half of 2026. Revenue and profit increased significantly, and full-year guidance was maintained. Other stocks also moved in pre-market trading.

Avi Kapoor

SL Science Holding, Alamos Gold And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

U.S. stock futures mixed. SL Science shares fall 11.4% after reporting financial results. Other stocks also down in pre-market trading.

Avi Kapoor

This Piper Sandler Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations From Tuesday

Top Wall Street analysts begin coverage of Aclaris Therapeutics, Orion Group Holdings, and Take-Two Interactive.

Avi Kapoor

This Applied Materials Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Citations for AMAT, BMEA, ACRS, KALU, SION.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-62.06M

Investing Cash Flow (TTM)

3.53M

Financing Cash Flow (TTM)

52.29M

Free Cash Flow (TTM)

-62.18M

Capital Expenditure (TTM)

-118.00K

Net Change in Cash (TTM)

-6.24M

Analyst Trends and Forecast

2

Apr

2

May

1

Jun

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$453.08M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

58.18

PB Ratio (TTM)

4.37

Earnings Yield % (TTM)

-15.68%

Earnings Yield % (FWD)

-16.22%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.85

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$19.17M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-